In this review, the authors outline the management of advanced heart failure and discuss difficulties in the interpretation of the evidence-base, practical problems of drug-based therapy, and future novel strategies
Heart failure is an increasingly common and costly chronic disorder, with a rising prevalence of at ...
Despite tremendous breakthroughs in drug-based and device-based therapy, heart failure continues to ...
The authors of the article have analyzed the problem of advanced heart failure (AHF). Despite signif...
peer reviewedThe incidence of heart failure is consistently progressing among our population; it now...
Patients with advanced heart failure have poor prognosis despite traditional pharmacological therapi...
Advanced systolic heart failure refractory to ambulatory pharmacotherapy continues to be a clinical ...
Heart failure (HF) is a major cause of mortality, hospitalizations, and reduced quality of life and ...
Due to the ageing of the population and increased survival of patients with acute coronary artery di...
Therapy based on disease-modifier drugs is among the required criteria to diagnose advanced heart fa...
This article updates the Heart Failure Association of the European Society of Cardiology (ESC) 2007 ...
This article updates the Heart Failure Association of the European Society of Cardiology (ESC) 2007 ...
Hospitalization for heart failure (HF) marks a substantial crossroad for patients, as greater than o...
Background: Some 4.6 million Americans are estimated to suffer from heart failure, and approximately...
Sunit-Preet Chaudhry,1 Garrick C Stewart2 1Division of Cardiology, St Vincent Indianapolis, Indianap...
Despite the advancement in medicine, management of heart failure (HF), which usually presents as a d...
Heart failure is an increasingly common and costly chronic disorder, with a rising prevalence of at ...
Despite tremendous breakthroughs in drug-based and device-based therapy, heart failure continues to ...
The authors of the article have analyzed the problem of advanced heart failure (AHF). Despite signif...
peer reviewedThe incidence of heart failure is consistently progressing among our population; it now...
Patients with advanced heart failure have poor prognosis despite traditional pharmacological therapi...
Advanced systolic heart failure refractory to ambulatory pharmacotherapy continues to be a clinical ...
Heart failure (HF) is a major cause of mortality, hospitalizations, and reduced quality of life and ...
Due to the ageing of the population and increased survival of patients with acute coronary artery di...
Therapy based on disease-modifier drugs is among the required criteria to diagnose advanced heart fa...
This article updates the Heart Failure Association of the European Society of Cardiology (ESC) 2007 ...
This article updates the Heart Failure Association of the European Society of Cardiology (ESC) 2007 ...
Hospitalization for heart failure (HF) marks a substantial crossroad for patients, as greater than o...
Background: Some 4.6 million Americans are estimated to suffer from heart failure, and approximately...
Sunit-Preet Chaudhry,1 Garrick C Stewart2 1Division of Cardiology, St Vincent Indianapolis, Indianap...
Despite the advancement in medicine, management of heart failure (HF), which usually presents as a d...
Heart failure is an increasingly common and costly chronic disorder, with a rising prevalence of at ...
Despite tremendous breakthroughs in drug-based and device-based therapy, heart failure continues to ...
The authors of the article have analyzed the problem of advanced heart failure (AHF). Despite signif...
DOI
Add to ORKG